Has Yousif Yonan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,411 in general payments to Yousif Yonan, MD across 198 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yousif Yonan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yousif Yonan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yousif Yonan, MD

Dermatology · Paradise Valley, AZNPI 1174918387

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,051, more than ten times the $143 reported in 2021.

$4,411in general payments, 2019–2025

Across 198 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$757
AbbVie$731
Revance Therapeutics, Inc.$408
UCB, Inc.$304
Incyte Corporation$266
Dermavant Sciences, Inc.$248
plus $2K from 20 others

What the payments were for

Food & beverage$4,14494%
Education$2676%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	24	$757
AbbVie	36	$731
Revance Therapeutics, Inc.	6	$408
UCB, Inc.	12	$304
Incyte Corporation	14	$266
Dermavant Sciences, Inc.	13	$248
Arcutis Biotherapeutics, Inc.	17	$231
Organon	17	$229
Ortho Dermatologics, A Division Of Bausch Health US, LLC	10	$184
Sanofi	6	$153
Amgen	6	$136
Galderma Laboratories, L.p.	7	$120
Lilly USA, LLC	6	$115
Botanix SB Inc	4	$94
Regeneron Healthcare Solutions, Inc.	2	$59
E.r. Squibb & Sons, L.L.C.	3	$55
LEO Pharma Inc.	2	$51
Sun Pharmaceutical Industries Inc.	2	$50
Kyowa Kirin, Inc.	2	$47
Pfizer	2	$39
LNHC, Inc	2	$32
Novartis	1	$29
Almirall LLC	1	$22
VYNE Pharmaceuticals Inc.	1	$22
Optos, Inc.	1	$16
Solta Medical, A Division Of Bausch Health US, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DAXXIFY$250
Tremfya$125

How this compares

$4,411 in reported general payments places this provider in the 65th percentile of 305 dermatology providers in Arizona.

See all dermatology providers in Arizona →

Medicare billing

Part B allowed, 2024

$211,497

Medicare patients

548

Services billed

4,105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	49	$2,465
Ketoconazole	140	$2,042
Fluorouracil	25	$1,656
Fluocinonide	37	$1,438
MethotrexateMethotrexate Sodium	21	$558
Triamcinolone Acetonide	61	$540
Doxycycline Hyclate	40	$515
Clindamycin Phosphate	13	$336
Mupirocin	39	$317
Minoxidil	17	$310
Hydrocortisone	54	$252
ValacyclovirValacyclovir Hcl	21	$232
Cefadroxil	13	$90

Paid to pharmacies, not to this prescriber.

Other dermatology in Paradise Valley

Susan van DykeParadise Valley$164K
Lindsay AckermanPhoenix$1.6M
Kathleen ObrienTucson$742K
Nathalie ZeitouniPhoenix$584K
John KastelerGilbert$456K
Anthony NuaraScottsdale$432K
Carsten HamannPhoenix$364K
James SlighTucson$238K
Aaron MangoldScottsdale$171K
Sheila FarhangOro Valley$153K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →